quinoxalines has been researched along with Lupus Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barber, DF; Cariaga, AE; Carrera, AC; García, E; Puri, KD; Rojas, JM; Steiner, BH; Suárez-Fueyo, A | 1 |
| Balomenos, D; Barber, DF; Bartolomé, A; Camps, M; Carrera, AC; Fernandez-Arias, C; Flores, JM; Hernandez, C; Martinez-A, C; Redondo, C; Rodríguez, S; Rommel, C; Rückle, T; Schwarz, MK | 1 |
2 other study(ies) available for quinoxalines and Lupus Nephritis
| Article | Year |
|---|---|
Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
Topics: Adenosine; Animals; Antibodies, Antinuclear; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Class I Phosphatidylinositol 3-Kinases; Class Ib Phosphatidylinositol 3-Kinase; Cytokines; Dose-Response Relationship, Drug; Flow Cytometry; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Count; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Microscopy, Confocal; Molecular Structure; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinazolinones; Quinoxalines; Survival Analysis; Thiazolidinediones | 2014 |
PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Female; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Mice, Mutant Strains; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Thiazolidinediones | 2005 |